152 related articles for article (PubMed ID: 7930246)
1. New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group.
Weaver WD; Hartmann JR; Anderson JL; Reddy PS; Sobolski JC; Sasahara AA
J Am Coll Cardiol; 1994 Nov; 24(5):1242-8. PubMed ID: 7930246
[TBL] [Abstract][Full Text] [Related]
2. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
[TBL] [Abstract][Full Text] [Related]
3. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
[TBL] [Abstract][Full Text] [Related]
4. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
Bode C; Schoenermark S; Schuler G; Zimmermann R; Schwarz F; Kuebler W
Am J Cardiol; 1988 May; 61(13):971-4. PubMed ID: 2452564
[TBL] [Abstract][Full Text] [Related]
6. Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction.
Gulba DC; Fischer K; Barthels M; Polensky U; Reil GH; Daniel WG; Welzel D; Lichtlen PR
Am J Cardiol; 1989 May; 63(15):1025-31. PubMed ID: 2495709
[TBL] [Abstract][Full Text] [Related]
7. Multicenter dose-finding trial for thrombolysis with urokinase preactivated pro-urokinase (TCL 598) in acute myocardial infarction. German Preactivated Pro-Urokinase Study Group.
Gulba DC; Bode C; Sen S; Topp J; Fischer K; Wolf H; Hecker H
Cathet Cardiovasc Diagn; 1992 Jul; 26(3):177-84. PubMed ID: 1617708
[TBL] [Abstract][Full Text] [Related]
8. Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
Wall TC; Califf RM; George BS; Ellis SG; Samaha JK; Kereiakes DJ; Worley SJ; Sigmon K; Topol EJ
J Am Coll Cardiol; 1992 Mar; 19(3):482-9. PubMed ID: 1537998
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
[TBL] [Abstract][Full Text] [Related]
10. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
[TBL] [Abstract][Full Text] [Related]
11. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction.
Purvis JA; McNeill AJ; Siddiqui RA; Roberts MJ; McClements BM; McEneaney D; Campbell NP; Khan MM; Webb SW; Wilson CM
J Am Coll Cardiol; 1994 Jan; 23(1):6-10. PubMed ID: 8277097
[TBL] [Abstract][Full Text] [Related]
13. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
Verheugt FW; Liem A; Zijlstra F; Marsh RC; Veen G; Bronzwaer JG
J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569
[TBL] [Abstract][Full Text] [Related]
14. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
Gulba DC; Barthels M; Westhoff-Bleck M; Jost S; Rafflenbeul W; Daniel WG; Hecker H; Lichtlen PR
Circulation; 1991 Mar; 83(3):937-44. PubMed ID: 1900225
[TBL] [Abstract][Full Text] [Related]
15. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
[TBL] [Abstract][Full Text] [Related]
16. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
Ouriel K; Kandarpa K; Schuerr DM; Hultquist M; Hodkinson G; Wallin B
J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
[TBL] [Abstract][Full Text] [Related]
18. HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study.
Sun Y; Liu X; Guo L; Pang W; Guo X; Sun Z; Li Z; Cui X; Li H; Tao G; Wang L; Zhou C; Liu Y; Shan H; Wang M; Liu M; Li J; Yin L; Hu D
Int J Cardiol; 2014 Mar; 172(2):326-31. PubMed ID: 24525155
[TBL] [Abstract][Full Text] [Related]
19. HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction: results of a dose-finding study (HIT-II) by the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte.
von Essen R; Zeymer U; Tebbe U; Jessel A; Kwasny H; Mateblowski M; Niederer W; Wagner J; Mäurer W; von Leitner ER; Haerten K; Roth M; Neuhaus KL
Coron Artery Dis; 1998; 9(5):265-72. PubMed ID: 9710686
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of saruplase: angiographic findings.
Meyer J
Int J Clin Pract Suppl; 1998 Nov; 99():9-15. PubMed ID: 10344035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
